Product Uses Include
The G-switch™ Direct Modulators have been developed with an emphasis on creating highly potent cell permeable reagents that directly target the Rho family of small G-proteins. Our Direct Activator reagents are based on the catalytic domain of the bacterial CNF toxins, which are covalently attached to a proprietary cell penetrating moiety. Rho Activator II (Cat# CN03) enters the cell and activates Rho GTPase isoforms by deamidating glutamine-63, which is located in the Switch II region of these GTPases (1). This modification converts glutamine-63 to glutamate, which blocks intrinsic and GAP stimulated GTPase activity resulting in constitutively active Rho (2). Rho Activator II robustly increases the level of GTP bound RhoA within 2-4 h after addition to the culture medium, providing a more rapid alternative to transfection based methods for introducing activators like GEFs into cells. Moreover, the targeted action of Rho Activator II makes it far more attractive tool for the study of Rho GTPase signaling than classic indirect activators (e.g. LPA) that concomitantly activate other signaling pathways (e.g. Ras, PI3K and PLC).
For product Datasheets and MSDSs please click on the PDF links below. For additional information, click on the FAQs tab above or contact our Technical Support department at firstname.lastname@example.org
Rom S., et al. 2013. Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood–brain barrier. Am. J. Pathol. doi:10.1016/j.ajpath.2013.07.033.
Rom S., et al. 2012. Glycogen synthase kinase 3b inhibition prevents monocyte migration across brain endothelial cells via Rac1-GTPase suppression and down-regulation of active integrin conformation. Am. J. Pathol. 181:1414–1425.
Question 1: Can the direct Rho/Rac/Cdc42 activator CN04 be used with cells growing in culture?
Answer 1: Yes, CN04 is specifically designed to be used as a Rho/Rac/Cdc42 activator with cultured cells. The active site of CN04 is based on the catalytic domain of the bacterial cytotoxic necrotizing factor (CNF) toxins. The catalytic domain of CN04 is covalently attached to a proprietary cell penetrating moiety. Upon entry into the cell, CN04 directly activates Rho GTPase isoforms by deamidating glutamine-63 of Rho and glutamine-61 of Rac and Cdc42 in their respective Switch II regions. This modification converts glutamine-63 to glutamate, which blocks intrinsic and GAP-stimulated GTPase activity, resulting in constitutively active endogenous Rho, Rac and Cdc42. CN04 robustly increases the level of GTP-bound RhoA, Rac1 and Cdc42 within 2-4 h after addition to the culture medium.
Question 2: How can I assess whether Rho, Rac and/or Cdc42 activity is changing in my cells following CN04 treatment?
Answer 2: There are multiple ways to measure changes in Rho, Rac and Cdc42 activity. To visualize a change in a cell’s cytoskeleton mediated by Rho family proteins, we recommend examining stress fiber formation and edge ruffling with fluorescently-labeled phalloidin (Cat. # PHDG1, PHDH1, PHDN1, PHDR1). These Acti-stain phalloidins label F-actin-containing structures and fibers. Activation of Rho family proteins can be directly quantified with either our pull-down or G-LISA activation assays. For RhoA, use the BK036 pull-down or BK 124 G-LISA. For Rac1, use the BK035 pull-down or BK128 G-LISA. For Cdc42, use the BK034 pull-down or BK127 G-LISA.
If you have any questions concerning this product, please contact our Technical Service department at email@example.com.